2016 Q4 Form 10-Q Financial Statement

#000114420416132423 Filed on November 08, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $3.336M $3.098M $2.668M
YoY Change 13.79% 16.13% 4040.1%
Cost Of Revenue $3.560M $3.280M $2.949M
YoY Change 21.92% 11.23% 864.18%
Gross Profit -$227.8K -$184.6K -$281.4K
YoY Change -2210.37% -34.4% 16.57%
Gross Profit Margin -6.83% -5.96% -10.55%
Selling, General & Admin $1.740M $1.510M $1.764M
YoY Change -13.43% -14.38% -3.85%
% of Gross Profit
Research & Development $540.0K $690.0K $529.6K
YoY Change -16.92% 30.29% 51.6%
% of Gross Profit
Depreciation & Amortization $220.0K $210.0K $81.70K
YoY Change 10.0% 157.04% 9.33%
% of Gross Profit
Operating Expenses $2.510M $2.411M $2.476M
YoY Change -11.62% -2.62% -4.15%
Operating Profit -$2.733M -$2.596M -$2.748M
YoY Change -3.44% -5.52% -2.74%
Interest Expense -$10.00K -$80.00K $8.702K
YoY Change -50.0% -1019.33% 386.69%
% of Operating Profit
Other Income/Expense, Net -$30.00K -$84.18K -$4.089K
YoY Change 1958.6% -104.07%
Pretax Income -$2.750M -$2.680M -$2.760M
YoY Change -3.85% -2.9% 1.47%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.747M -$2.680M -$2.762M
YoY Change -4.12% -2.96% 1.37%
Net Earnings / Revenue -82.34% -86.52% -103.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$30.94K -$33.34K -$38.98K
COMMON SHARES
Basic Shares Outstanding 90.70M shares 80.39M shares 70.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.47M $5.190M $6.740M
YoY Change 258.24% -23.0% -32.73%
Cash & Equivalents $13.47M
Short-Term Investments
Other Short-Term Assets $200.0K $410.0K $480.0K
YoY Change -71.83% -14.58% -88.63%
Inventory $3.093M $3.050M $2.375M
Prepaid Expenses
Receivables $40.99K $20.00K $225.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.80M $8.670M $9.870M
YoY Change 132.4% -12.16% -38.45%
LONG-TERM ASSETS
Property, Plant & Equipment $2.435M $2.450M $2.647M
YoY Change -4.74% -7.44% -8.11%
Goodwill
YoY Change
Intangibles $7.390M $7.306M
YoY Change 0.35% 32.16%
Long-Term Investments $1.020M $1.050M $1.190M
YoY Change -16.55% -11.76% -14.39%
Other Assets
YoY Change
Total Long-Term Assets $10.84M $10.90M $11.15M
YoY Change -2.02% -2.21% 4.62%
TOTAL ASSETS
Total Short-Term Assets $16.80M $8.670M $9.870M
Total Long-Term Assets $10.84M $10.90M $11.15M
Total Assets $27.64M $19.57M $21.02M
YoY Change 51.08% -6.88% -21.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.340M $1.380M $1.239M
YoY Change 4.43% 11.4% 152.82%
Accrued Expenses $1.600M $1.280M $1.005M
YoY Change 18.57% 27.33% -45.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $170.0K
YoY Change -100.0% 0.0%
Long-Term Debt Due $310.0K $330.0K $330.0K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $3.249M $2.990M $3.087M
YoY Change 2.76% -3.14% 23.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $310.0K $620.0K
YoY Change -100.0% -50.0%
Other Long-Term Liabilities $60.00K $100.0K $3.100M
YoY Change -98.06% -96.77% -3.73%
Total Long-Term Liabilities $60.00K $410.0K $3.720M
YoY Change -98.24% -88.98% 15.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.249M $2.990M $3.087M
Total Long-Term Liabilities $60.00K $410.0K $3.720M
Total Liabilities $3.308M $3.400M $6.799M
YoY Change -49.63% -50.0% 3.65%
SHAREHOLDERS EQUITY
Retained Earnings -$78.14M -$63.69M
YoY Change 17.4% 27.55%
Common Stock $907.00 $709.00
YoY Change 27.75% 10.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.33M $16.17M $14.22M
YoY Change
Total Liabilities & Shareholders Equity $27.64M $19.57M $21.02M
YoY Change 51.08% -6.88% -21.26%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$2.747M -$2.680M -$2.762M
YoY Change -4.12% -2.96% 1.37%
Depreciation, Depletion And Amortization $220.0K $210.0K $81.70K
YoY Change 10.0% 157.04% 9.33%
Cash From Operating Activities -$1.910M -$2.090M -$1.260M
YoY Change -22.36% 65.87% -19.75%
INVESTING ACTIVITIES
Capital Expenditures -$310.0K -$140.0K -$200.0K
YoY Change 181.82% -30.0% -45.95%
Acquisitions
YoY Change
Other Investing Activities $130.0K -$110.0K $0.00
YoY Change -100.0%
Cash From Investing Activities -$190.0K -$240.0K -$200.0K
YoY Change 72.73% 20.0% -89.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.38M 4.680M 0.000
YoY Change -2631.71% -100.0%
NET CHANGE
Cash From Operating Activities -1.910M -2.090M -1.260M
Cash From Investing Activities -190.0K -240.0K -200.0K
Cash From Financing Activities 10.38M 4.680M 0.000
Net Change In Cash 8.280M 2.350M -1.460M
YoY Change -377.85% -260.96% -125.04%
FREE CASH FLOW
Cash From Operating Activities -$1.910M -$2.090M -$1.260M
Capital Expenditures -$310.0K -$140.0K -$200.0K
Free Cash Flow -$1.600M -$1.950M -$1.060M
YoY Change -31.91% 83.96% -11.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-298970 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
1000000 USD
xxii Milestone Payment
MilestonePayment
150000 USD
xxii Lease Payments
LeasePayments
92250 USD
CY2016Q3 xxii Lease Payments
LeasePayments
36131 USD
CY2015Q3 xxii Lease Payments
LeasePayments
30750 USD
CY2016Q2 xxii Litigation Settlement Shares To Be Issued
LitigationSettlementSharesToBeIssued
2077555 shares
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5091791 USD
xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
196 USD
xxii Adjustment To Additional Paid In Capital Warrant Liability Reclassified
AdjustmentToAdditionalPaidInCapitalWarrantLiabilityReclassified
2810000 USD
xxii Amortization Of License Fees
AmortizationOfLicenseFees
73516 USD
xxii Amortization Of License Fees
AmortizationOfLicenseFees
73516 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1000603 USD
us-gaap Share Based Compensation
ShareBasedCompensation
677076 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2210972 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
30873 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
369731 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
386072 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
203565 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-91945 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
248683 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4863017 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7982309 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
22796 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
125511 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-339675 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-362234 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
196 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5541583 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9774751 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34776 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1430208 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
338891 USD
xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
-173078 USD
xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
-30857 USD
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
34500 USD
xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
-45000 USD
xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
-60000 USD
us-gaap Accretion Expense
AccretionExpense
29011 USD
us-gaap Accretion Expense
AccretionExpense
18034 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
550191 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
497583 USD
us-gaap Interest Paid Net
InterestPaidNet
10507 USD
us-gaap Interest Paid Net
InterestPaidNet
7296 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
180560 USD
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
242925 USD
xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
9749 USD
xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
12677 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
325000 USD
CY2015Q3 us-gaap Cash
Cash
6741578 USD
CY2014Q4 us-gaap Cash
Cash
6402687 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
236723 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
316879 USD
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
CY2016Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
155623 USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 USD
CY2016Q3 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1867335 USD
CY2015Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1816857 USD
CY2016Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
1810000 USD
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
5387000 USD
CY2015Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
1910000 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
110623 USD
CY2016Q3 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
424960 USD
CY2015Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
342707 USD
CY2016Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
910730 USD
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
657389 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
380689 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
331960 USD
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
129807 USD
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
115671 USD
CY2015Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
242658 USD
CY2015 xxii Percentage Of Orders Shipped
PercentageOfOrdersShipped
0.4 pure
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
329321 USD
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
3838000 USD
CY2016Q3 us-gaap Advertising Expense
AdvertisingExpense
24000 USD
us-gaap Advertising Expense
AdvertisingExpense
259000 USD
CY2015Q3 us-gaap Advertising Expense
AdvertisingExpense
71000 USD
us-gaap Advertising Expense
AdvertisingExpense
186000 USD
CY2016Q1 xxii Warrant Exercisable Per Share
WarrantExercisablePerShare
3.36
CY2016Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3125657 USD
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3016246 USD
CY2016Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
102134 USD
CY2015Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
95361 USD
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
798832 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
555814 USD
CY2016Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
19076 USD
CY2015Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
0 USD
CY2014Q2 us-gaap Equity Method Investments
EquityMethodInvestments
250000 USD
CY2014 xxii Finite Lived Intangible Assets Acquired With Notes Payable
FiniteLivedIntangibleAssetsAcquiredWithNotesPayable
925730 USD
CY2014Q4 us-gaap Other Commitment
OtherCommitment
1213000 USD
CY2016Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
635024 USD
CY2015Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
616520 USD
CY2014Q4 us-gaap Severance Costs1
SeveranceCosts1
624320 USD
CY2014Q4 xxii Severance Term
SeveranceTerm
P36M
CY2014Q4 xxii Accrued Severance Liabilities Current
AccruedSeveranceLiabilitiesCurrent
212012 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
412308 USD
CY2016Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2618 shares
CY2016Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
67042 shares
CY2016Q1 xxii Warrants Expired And Unexercised
WarrantsExpiredAndUnexercised
6831115 shares
CY2014 xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
7367915 USD
CY2014 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
3676691 USD
CY2014 xxii Inducement Costs From Warrant Amendments
InducementCostsFromWarrantAmendments
144548 USD
CY2015 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
144550 USD
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
14602 USD
CY2014Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3042846 USD
xxii Reclassification Of Warrant Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantLiabilityToCapitalInExcessOfParValue
2810000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
14602 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
199556 USD
CY2015Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
27723 USD
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10653469 shares
CY2014 xxii Warrants Issued In Conjunction With Consulting Agreement
WarrantsIssuedInConjunctionWithConsultingAgreement
4250000 shares
CY2014 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
1247443 shares
CY2014 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
18383 shares
CY2015 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
369 shares
xxii Warrants With Provision Of Anti Dilution
WarrantsWithProvisionOfAntiDilution
94721 shares
xxii Warrants Without Provision Of Anti Dilution
WarrantsWithoutProvisionOfAntiDilution
9437200 shares
CY2015 xxii Warrants Issued In Conjunction With Registered Direct Offering
WarrantsIssuedInConjunctionWithRegisteredDirectOffering
3000000 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13674409 shares
CY2015 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
40000 shares
xxii Warrants Issued In Conjunction With Registered Direct Offering
WarrantsIssuedInConjunctionWithRegisteredDirectOffering
2500000 shares
xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
67042 shares
xxii Number Of Warrants Expired
NumberOfWarrantsExpired
6831115 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16634778 shares
xxii Unexercisable Warrants
UnexercisableWarrants
2000000 shares
CY2015Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
75000 USD
CY2014Q1 us-gaap License Costs
LicenseCosts
85681 USD
CY2015Q4 us-gaap License Costs
LicenseCosts
150000 USD
CY2016Q3 xxii Minimum Annual Royalties In Year Five
MinimumAnnualRoyaltiesInYearFive
25000 USD
CY2016Q3 xxii Minimum Annual Royalties After Year Five
MinimumAnnualRoyaltiesAfterYearFive
50000 USD
CY2016Q3 xxii Minimum Annual Royalties In Year Three
MinimumAnnualRoyaltiesInYearThree
10000 USD
CY2016Q3 xxii Minimum Royalty Fee Payments Due In Year Four
MinimumRoyaltyFeePaymentsDueInYearFour
15000 USD
xxii Lease Payments
LeasePayments
108393 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
156000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
169000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
169000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
169000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
141000 USD
CY2015Q4 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
3750 USD
CY2015Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
25000 sqft
CY2016Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80386519 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70798879 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
76826949 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67225308 shares
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1586000 USD
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
204860 USD
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
314743 USD
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0131 pure
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0160 pure
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y10M13D
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P8Y10M28D
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
300000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
890000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3161642 shares
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70000 shares
CY2015 xxii Share Based Compensation Arrangement By Sharebased Payment Award Options Reinstated In Period
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsReinstatedInPeriod
50000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2221642 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2711642 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.61
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.69
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.1
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.38
CY2015 xxii Share Based Compensation Arrangements By Share Based Payment Award Options Reinstated In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsReinstatedInPeriodWeightedAverageExercisePrice
0.69
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2489037 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.97
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5650679 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.04
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2641281 USD
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1158762 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2489037 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2121642 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1242110 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
206500 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001347858
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Trading Symbol
TradingSymbol
XXII
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90698113 shares
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-84176 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4089 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
2411194 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
2476180 USD
us-gaap Operating Expenses
OperatingExpenses
8646767 USD
us-gaap Operating Expenses
OperatingExpenses
8453161 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-179748 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1070991 USD
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82198113 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82198113 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71066844 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71066844 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 37.4pt; MARGIN: 0cm 0cm 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0cm 0cm 0pt"> <strong><i><font style="FONT-SIZE: 10pt"> Reclassifications</font></i></strong><i><font style="FONT-SIZE: 10pt">-</font></i> <font style="FONT-SIZE: 10pt"> Certain items in the 2015 financial statements have been reclassified to conform to the 2016 classification.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 40.7pt; MARGIN: 0cm 0cm 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0cm 0cm 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></strong><strong><font style="FONT-SIZE: 10pt">-</font></strong> <font style="FONT-SIZE: 10pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
3203025 USD
CY2015Q4 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
2816953 USD
xxii Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
4682764 USD
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3779522 USD
xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
2089 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15182600 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19836420 shares
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
38000 USD
CY2016Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
46995 USD
CY2016Q3 xxii Warrants Outstanding
WarrantsOutstanding
9531921 shares
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3111607 USD
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3246867 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 USD
CY2016Q3 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-10-31
xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
2810000 USD
xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
0 USD

Files In Submission

Name View Source Status
0001144204-16-132423-index-headers.html Edgar Link pending
0001144204-16-132423-index.html Edgar Link pending
0001144204-16-132423.txt Edgar Link pending
0001144204-16-132423-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v451435_10q.htm Edgar Link pending
v451435_ex31-1.htm Edgar Link pending
v451435_ex31-2.htm Edgar Link pending
v451435_ex32-1.htm Edgar Link pending
xxii-20160930.xml Edgar Link completed
xxii-20160930.xsd Edgar Link pending
xxii-20160930_cal.xml Edgar Link unprocessable
xxii-20160930_def.xml Edgar Link unprocessable
xxii-20160930_lab.xml Edgar Link unprocessable
xxii-20160930_pre.xml Edgar Link unprocessable